Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

What Are the Risks of Tarceva?

April 26, 2017Tarceva

0

Posted

What Are the Risks of Tarceva?

1 Answer

0

Posted

Tarceva is a brand name prescription medication containing the drug erlotinib. It is approved by the U.S. Food and Drug Administration to treat advanced non-small cell lung cancer in patients who have been treated in the past with other chemotherapy agents, explains the drug’s manufacturer OSI Pharmaceuticals. It is also approved to treat advanced or inoperable pancreatic cancer in patients who are also taking the chemotherapy drug gemcitabine. Tarceva is administered orally. Like all medications, it carries the risk of side effects.